(NYSE: BHC) Bausch Health Companies's forecast annual revenue growth rate of 2.02% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Bausch Health Companies's revenue in 2025 is $9,858,000,000.On average, 4 Wall Street analysts forecast BHC's revenue for 2025 to be $3,728,392,401,802, with the lowest BHC revenue forecast at $3,712,546,886,632, and the highest BHC revenue forecast at $3,741,538,447,642. On average, 4 Wall Street analysts forecast BHC's revenue for 2026 to be $3,835,647,125,505, with the lowest BHC revenue forecast at $3,798,807,874,346, and the highest BHC revenue forecast at $3,865,048,414,188.
In 2027, BHC is forecast to generate $3,855,713,057,585 in revenue, with the lowest revenue forecast at $3,758,179,011,997 and the highest revenue forecast at $3,956,645,476,204.